CRISPR-Cas systems are prokaryotic immune ... photoreceptors when delivered with adeno-associated viral gene therapy. SeqCas9, a Cas9 variant from the Streptococcus family, recognizes a simple ...
A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...
CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...
Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...
and recently added to its portfolio with a therapy for blood disorders sickle cell disease (SCD) and transfusion-dependent beta thalassaemia. It has broadened its R&D focus in recent years to ...
The drugmaker also won a CHMP endorsement for its CAR-T therapy Breyanzi ... get a speedy FDA review after the agency granted priority review to the company’s new drug application.
In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...